-
1
-
-
77953142652
-
Immunogenicity and Safety of H5N1 A/Vietnam/1194/2004 (Clade 1) AS03-adjuvanted prepandemic candidate influenza vaccines in children aged 3 to 9 years: A phase ii, randomized, open, controlled study
-
Diez-Domingo J, Garces-Sanchez M, Baldo JM, et al. Immunogenicity and Safety of H5N1 A/Vietnam/1194/2004 (Clade 1) AS03-adjuvanted prepandemic candidate influenza vaccines in children aged 3 to 9 years: a phase ii, randomized, open, controlled study. Pediatr Infect Dis J 2010; 29:e35-46.
-
(2010)
Pediatr Infect Dis J
, vol.29
-
-
Diez-Domingo, J.1
Garces-Sanchez, M.2
Baldo, J.M.3
-
2
-
-
77951883155
-
Safety and cross-reactive immunogenicity of candidate AS03-adjuvanted prepandemic H5N1 influenza vaccines: A randomized controlled phase 1/2 trial in adults
-
Langley JM, Frenette L, Ferguson L, et al. Safety and cross-reactive immunogenicity of candidate AS03-adjuvanted prepandemic H5N1 influenza vaccines: a randomized controlled phase 1/2 trial in adults. J Infect Dis 2010; 201:1644-53.
-
(2010)
J Infect Dis
, vol.201
, pp. 1644-1653
-
-
Langley, J.M.1
Frenette, L.2
Ferguson, L.3
-
3
-
-
34547837401
-
Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: A randomised controlled trial
-
Leroux-Roels I, Borkowski A, Vanwolleghem T, et al. Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial. Lancet 2007; 370:580-9.
-
(2007)
Lancet
, vol.370
, pp. 580-589
-
-
Leroux-Roels, I.1
Borkowski, A.2
Vanwolleghem, T.3
-
4
-
-
70349861815
-
Immunogenicity and tolerability of an AS03(A)-adjuvanted prepandemic influenza vaccine: A phase III study in a large population of Asian adults
-
Chu DW, Hwang SJ, Lim FS, et al. Immunogenicity and tolerability of an AS03(A)-adjuvanted prepandemic influenza vaccine: a phase III study in a large population of Asian adults. Vaccine 2009; 27:7428-35.
-
(2009)
Vaccine
, vol.27
, pp. 7428-7435
-
-
Chu, D.W.1
Hwang, S.J.2
Lim, F.S.3
-
5
-
-
70350025172
-
Single dose vaccination with AS03-adjuvanted H5N1 vaccines in a randomized trial induces strong and broad immune responsiveness to booster vaccination in adults
-
Schwarz TF, Horacek T, Knuf M, et al. Single dose vaccination with AS03-adjuvanted H5N1 vaccines in a randomized trial induces strong and broad immune responsiveness to booster vaccination in adults. Vaccine 2009; 27:6284-90.
-
(2009)
Vaccine
, vol.27
, pp. 6284-6290
-
-
Schwarz, T.F.1
Horacek, T.2
Knuf, M.3
-
6
-
-
79953301948
-
Immunogenicity Profile of a 3.75-{micro}g hemagglutinin pandemic rH5N1 split virion AS03A-Adjuvanted vaccine in elderly persons: A randomized trial
-
Heijmans S, De Meulemeester M, Reynders P, et al. Immunogenicity Profile of a 3.75-{micro}g hemagglutinin pandemic rH5N1 split virion AS03A-Adjuvanted vaccine in elderly persons: a randomized trial. J Infect Dis 2011; 203:1054-62.
-
(2011)
J Infect Dis
, vol.203
, pp. 1054-1062
-
-
Heijmans, S.1
De Meulemeester, M.2
Reynders, P.3
-
8
-
-
77953727656
-
Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: Open label, randomised, parallel group, multicentre study
-
Waddington CS, Walker WT, Oeser C, et al. Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study. BMJ 2010; 340:c2649.
-
(2010)
BMJ
, vol.340
-
-
Waddington, C.S.1
Walker, W.T.2
Oeser, C.3
-
9
-
-
77955560311
-
Immunogenicity and safety of AS03-adjuvanted 2009 influenza A H1N1 vaccine in children 6-35 months
-
Carmona A, Omenaca F, Tejedor JC, et al. Immunogenicity and safety of AS03-adjuvanted 2009 influenza A H1N1 vaccine in children 6-35 months. Vaccine 2010; 28:5837-44.
-
(2010)
Vaccine
, vol.28
, pp. 5837-5844
-
-
Carmona, A.1
Omenaca, F.2
Tejedor, J.C.3
-
10
-
-
79957824323
-
Immunogenicity and safety of AS03-adjuvanted H1N1 pandemic vaccines in children and adolescents
-
Garcia-Sicilia J, Gillard P, Carmona A, et al. Immunogenicity and safety of AS03-adjuvanted H1N1 pandemic vaccines in children and adolescents. Vaccine 2011; 29:4353-61.
-
(2011)
Vaccine
, vol.29
, pp. 4353-4361
-
-
Garcia-Sicilia, J.1
Gillard, P.2
Carmona, A.3
-
11
-
-
75249101993
-
Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03(A)-adjuvant: Preliminary report of an observer-blind, randomised trial
-
Roman F, Vaman T, Gerlach B, Markendorf A, Gillard P, Devaster JM. Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03(A)-adjuvant: Preliminary report of an observer-blind, randomised trial. Vaccine 2010; 28:1740-5.
-
(2010)
Vaccine
, vol.28
, pp. 1740-1745
-
-
Roman, F.1
Vaman, T.2
Gerlach, B.3
Markendorf, A.4
Gillard, P.5
Devaster, J.M.6
-
13
-
-
78751704276
-
Immunogenicity and safety of a two-dose schedule of whole-virion and AS03A-adjuvanted 2009 influenza A (H1N1) vaccines: A randomised, multicentre, agestratified, head-to-head trial
-
Nicholson KG, Abrams KR, Batham S, et al. Immunogenicity and safety of a two-dose schedule of whole-virion and AS03A-adjuvanted 2009 influenza A (H1N1) vaccines: a randomised, multicentre, agestratified, head-to-head trial. Lancet Infect Dis 2011; 11:91-101.
-
(2011)
Lancet Infect Dis
, vol.11
, pp. 91-101
-
-
Nicholson, K.G.1
Abrams, K.R.2
Batham, S.3
-
14
-
-
77955937857
-
AS03(A)-Adjuvanted influenza A (H1N1) 2009 vaccine for adults up to 85 years of age
-
Roman F, Vaman T, Kafeja F, Hanon E, Van Damme P. AS03(A)-Adjuvanted influenza A (H1N1) 2009 vaccine for adults up to 85 years of age. Clin Infect Dis 2010; 51:668-77.
-
(2010)
Clin Infect Dis
, vol.51
, pp. 668-677
-
-
Roman, F.1
Vaman, T.2
Kafeja, F.3
Hanon, E.4
Van Damme, P.5
-
15
-
-
78649690134
-
An adjuvanted pandemic influenza H1N1 vaccine provides early and long term protection in health care workers
-
Madhun AS, Akselsen PE, Sjursen H, et al. An adjuvanted pandemic influenza H1N1 vaccine provides early and long term protection in health care workers. Vaccine 2010; 29:266-73.
-
(2010)
Vaccine
, vol.29
, pp. 266-273
-
-
Madhun, A.S.1
Akselsen, P.E.2
Sjursen, H.3
-
16
-
-
85083607961
-
-
Health Canada Accessed 15 July 2010
-
Health Canada. Notice of Decision for AREPANRIX™ H1N1. http://www.hc-sc.gc.ca/dhp-mps/prodpharma/sbd-smd/phase1-decision/drugmed/ nd-ad-2009-arepanrix-h1n1-132070-eng.php. Accessed 15 July 2010.
-
Notice of Decision for AREPANRIX™ H1N1
-
-
-
17
-
-
80052228226
-
Immunogenicity of an inactivated monovalent 2009 H1N1 influenza vaccine in pregnant women
-
Jackson LA, Patel SM, Swamy GK, et al. Immunogenicity of an inactivated monovalent 2009 H1N1 influenza vaccine in pregnant women. J Infect Dis 2011; 6:854-63.
-
(2011)
J Infect Dis
, vol.6
, pp. 854-863
-
-
Jackson, L.A.1
Patel, S.M.2
Swamy, G.K.3
-
18
-
-
73049100357
-
Immune response after a single vaccination against 2009 influenza A H1N1 in USA: A preliminary report of two randomised controlled phase 2 trials
-
Plennevaux E, Sheldon E, Blatter M, Reeves-Hoche MK, Denis M. Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials. Lancet 2010; 375:41-8.
-
(2010)
Lancet
, vol.375
, pp. 41-48
-
-
Plennevaux, E.1
Sheldon, E.2
Blatter, M.3
Reeves-Hoche, M.K.4
Denis, M.5
-
19
-
-
72949104686
-
Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: A multicentre, doubleblind, randomised, placebo-controlled trial
-
Liang XF, Wang HQ, Wang JZ, et al. Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, doubleblind, randomised, placebo-controlled trial. Lancet 2010; 375:56-66.
-
(2010)
Lancet
, vol.375
, pp. 56-66
-
-
Liang, X.F.1
Wang, H.Q.2
Wang, J.Z.3
-
20
-
-
72449197465
-
A novel influenza A (H1N1) vaccine in various age groups
-
Zhu FC, Wang H, Fang HH, et al. A novel influenza A (H1N1) vaccine in various age groups. N Engl J Med 2009; 361:2414-23.
-
(2009)
N Engl J Med
, vol.361
, pp. 2414-2423
-
-
Zhu, F.C.1
Wang, H.2
Fang, H.H.3
-
21
-
-
77958099793
-
A single dose of unadjuvanted novel 2009 H1N1 vaccine is immunogenic and well tolerated in young and elderly adults
-
Talaat KR, Greenberg ME, Lai MH, et al. A single dose of unadjuvanted novel 2009 H1N1 vaccine is immunogenic and well tolerated in young and elderly adults. J Infect Dis 2010; 202:1327-37.
-
(2010)
J Infect Dis
, vol.202
, pp. 1327-1337
-
-
Talaat, K.R.1
Greenberg, M.E.2
Lai, M.H.3
-
22
-
-
72449172862
-
Response to a monovalent 2009 influenza A (H1N1) vaccine
-
Greenberg ME, Lai MH, Hartel GF, et al. Response to a monovalent 2009 influenza A (H1N1) vaccine. N Engl J Med 2009; 361:2405-13.
-
(2009)
N Engl J Med
, vol.361
, pp. 2405-2413
-
-
Greenberg, M.E.1
Lai, M.H.2
Hartel, G.F.3
-
23
-
-
80053628262
-
Predictors of immune response and reactogenicity to AS03B-adjuvanted split virion and nonadjuvanted whole virion H1N1 (2009) pandemic influenza vaccines
-
Andrews NJ, Walker WT, Finn A, et al. Predictors of immune response and reactogenicity to AS03B-adjuvanted split virion and nonadjuvanted whole virion H1N1 (2009) pandemic influenza vaccines. Vaccine 2011; 29:7913-9.
-
(2011)
Vaccine
, vol.29
, pp. 7913-7919
-
-
Andrews, N.J.1
Walker, W.T.2
Finn, A.3
-
24
-
-
79954610458
-
Immunogenicity of a monovalent 2009 influenza A (H1N1) vaccine among pregnant women: Lowered antibody response by prior seasonal vaccination
-
Ohfuji S, Fukushima W, Deguchi M, et al. Immunogenicity of a monovalent 2009 influenza A (H1N1) vaccine among pregnant women: lowered antibody response by prior seasonal vaccination. J Infect Dis 2011; 203:1301-8.
-
(2011)
J Infect Dis
, vol.203
, pp. 1301-1308
-
-
Ohfuji, S.1
Fukushima, W.2
Deguchi, M.3
-
25
-
-
80755161302
-
Effect of prior vaccination with a seasonal trivalent influenza vaccine on the antibody response to the influenza pandemic H1N1 2009 vaccine: A randomized controlled trial
-
Uno S, Kimachi K, Kei J, et al. Effect of prior vaccination with a seasonal trivalent influenza vaccine on the antibody response to the influenza pandemic H1N1 2009 vaccine: a randomized controlled trial. Microbiol Immunol 2011; 55:783-9.
-
(2011)
Microbiol Immunol
, vol.55
, pp. 783-789
-
-
Uno, S.1
Kimachi, K.2
Kei, J.3
-
26
-
-
56049127353
-
Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children
-
Nolan T, Richmond PC, Formica NT, et al. Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children. Vaccine 2008; 26: 6383-91.
-
(2008)
Vaccine
, vol.26
, pp. 6383-6391
-
-
Nolan, T.1
Richmond, P.C.2
Formica, N.T.3
-
27
-
-
71249164116
-
Priming with AS03 A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: An open non-randomised extension of a double-blind randomised primary study
-
Leroux-Roels I, Roman F, Forgus S, et al. Priming with AS03 A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: an open non-randomised extension of a double-blind randomised primary study. Vaccine 2010; 28:849-57.
-
(2010)
Vaccine
, vol.28
, pp. 849-857
-
-
Leroux-Roels, I.1
Roman, F.2
Forgus, S.3
-
28
-
-
77951832163
-
Immunogenicity and safety of intradermal influenza vaccination in healthy older adults
-
Chi RC, Rock MT, Neuzil KM. Immunogenicity and safety of intradermal influenza vaccination in healthy older adults. Clin Infect Dis 2010; 50:1331-8.
-
(2010)
Clin Infect Dis
, vol.50
, pp. 1331-1338
-
-
Chi, R.C.1
Rock, M.T.2
Neuzil, K.M.3
-
29
-
-
0035860619
-
Safety and immunogenicity of varying dosages of trivalent inactivated influenza vaccine administered by needle-free jet injectors
-
Jackson LA, Austin G, Chen RT, et al. Safety and immunogenicity of varying dosages of trivalent inactivated influenza vaccine administered by needle-free jet injectors. Vaccine 2001; 19:4703-9.
-
(2001)
Vaccine
, vol.19
, pp. 4703-4709
-
-
Jackson, L.A.1
Austin, G.2
Chen, R.T.3
-
30
-
-
58149100516
-
Half-vs full-dose trivalent inactivated influenza vaccine (2004-2005): Age, dose, and sex effects on immune responses
-
Engler RJ, Nelson MR, Klote MM, et al. Half-vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses. Arch Intern Med 2008; 168:2405-14.
-
(2008)
Arch Intern Med
, vol.168
, pp. 2405-2414
-
-
Engler, R.J.1
Nelson, M.R.2
Klote, M.M.3
-
31
-
-
34548241788
-
Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults
-
Belshe RB, Newman FK, Wilkins K, et al. Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults. Vaccine 2007; 25:6755-63.
-
(2007)
Vaccine
, vol.25
, pp. 6755-6763
-
-
Belshe, R.B.1
Newman, F.K.2
Wilkins, K.3
-
32
-
-
34250800842
-
A dose-response evaluation of inactivated influenza vaccine given intranasally and intramuscularly to healthy young adults
-
Atmar RL, Keitel WA, Cate TR, Munoz FM, Ruben F, Couch RB. A dose-response evaluation of inactivated influenza vaccine given intranasally and intramuscularly to healthy young adults. Vaccine 2007; 25:5367-73.
-
(2007)
Vaccine
, vol.25
, pp. 5367-5373
-
-
Atmar, R.L.1
Keitel, W.A.2
Cate, T.R.3
Munoz, F.M.4
Ruben, F.5
Couch, R.B.6
-
33
-
-
0037081382
-
Evaluation of a single dose of half strength inactivated influenza vaccine in healthy adults
-
Treanor J, Keitel W, Belshe R, et al. Evaluation of a single dose of half strength inactivated influenza vaccine in healthy adults. Vaccine 2002; 20:1099-105.
-
(2002)
Vaccine
, vol.20
, pp. 1099-1105
-
-
Treanor, J.1
Keitel, W.2
Belshe, R.3
-
34
-
-
79957453401
-
Dose-sparing H5N1 A/Indonesia/05/2005 pre-pandemic influenza vaccine in adults and elderly adults: A phase III, placebo-controlled, randomized study
-
Langley JM, Risi G, Caldwell M, et al. Dose-Sparing H5N1 A/Indonesia/05/2005 Pre-pandemic Influenza Vaccine in Adults and Elderly Adults: a Phase III, Placebo-Controlled, Randomized Study. J Infect Dis 2011; 203:1729-38.
-
(2011)
J Infect Dis
, vol.203
, pp. 1729-1738
-
-
Langley, J.M.1
Risi, G.2
Caldwell, M.3
|